Researchers track rare thyroid cancer to uncover its secrets
NCT ID NCT01660984
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 8 times
Summary
This study follows children and adults with medullary thyroid cancer (MTC), often linked to a genetic condition called MEN2. Researchers will track how the cancer grows and affects health over time using regular check-ups, blood tests, and imaging. No treatment is given, but participants receive standard care and may join other trials. The goal is to better understand MTC and its impact on the body and emotions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDULLARY THYROID CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive database study probes link between popular diabetes drugs and rare thyroid cancer
- Newborn screening study aims to catch rare diseases at birth
- Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial
- New imaging agent could improve detection of rare cancers
- New hope for advanced thyroid cancer: drug shows tumor-shrinking promise
- New PET scan agent aims to better detect rare tumors